Samuelson Doug 4
4 · Kairos Pharma, LTD. · Filed Nov 26, 2025
Insider Transaction Report
Form 4
Samuelson Doug
Chief Financial Officer
Transactions
- Award
COMMON STOCK
2025-10-08+152,672→ 293,039 total
Footnotes (2)
- [F1]Represents 152,672 restricted stock units ("RSUs") issued to the Reporting Person under the Kairos Pharma, Ltd. 2023 Equity Incentive Plan. The 152,672 RSUs are scheduled to vest in full on the first anniversary of the grant date.
- [F2]Consists of (1) 140,367 shares of common stock and (2) 152,672 RSUs which remain subject to vesting.